NCT06528483 2024-07-30preSAVEFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2 Not yet recruiting63 enrolled
NCT03629756 2024-05-24A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesArcus Biosciences, Inc.Phase 1 Completed48 enrolled